首页 > 最新文献

Clinical nutrition ESPEN最新文献

英文 中文
The anti-obesity effects of postbiotics: A systematic review of pre-clinical and clinical studies 益生菌的抗肥胖作用:临床前和临床研究的系统回顾。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-25 DOI: 10.1016/j.clnesp.2024.10.153
Maysa Eslami , Azin Pakmehr , Farzad Pourghazi , Atefe Kami , Hanieh-Sadat Ejtahed , Mohammadreza Mohajeri-Tehrani , Shirin Hasani-Ranjbar , Bagher Larijani

Background

The growing prevalence of obesity has become a major concern worldwide, therefore a great number of studies are conducted every day in the field of obesity. Since postbiotics are a newly introduced term, there is not much systematic evidence about their function and impact on obesity. We designed this study to systematically review the effect of different types of postbiotics on obesity.

Methods

A systematic search was conducted using PubMed, SCOPUS, and Web of Science databases up to August 2023. Both human and animal interventional studies that investigated the effects of any type of postbiotic on obesity and obesity-related factors were eligible. Screening, data extraction, and quality assessment were conducted independently by two researchers. The quality of the studies was appraised using Cochrane and Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE's) risk of bias tool.

Results

Of the 19373 retrieved studies, finally, 49 studies were included (9 human studies and 40 animal studies). Short-chain fatty acids and heat-killed (inactivated) bacteria were the most used postbiotics. In human clinical trials, inactivated Lactobacillus amylovorus (CP1563), Bifidobacterium animalis subsp. lactis (CECT 8145) and Pediococcus pentosaceus (LP28) were administered orally as postbiotics which improved body composition and anthropometric indices. Animal studies evaluated other types of postbiotics including muramyl dipeptide, cell-free extracts, urolithin A&B, extracellular Vesicles, exopolysaccharides, and surface Layer Proteins, supporting the anti-obesity effects of postbiotics.

Conclusion

Postbiotics seem to be a safe intervention and the results were in favor of a reduction in adipogenesis as well as an increase in energy expenditure. Further high-quality studies are required in this relatively new topic.
背景:肥胖症的发病率越来越高,已成为全世界关注的一个主要问题,因此,每天都有大量关于肥胖症的研究在进行。由于益生菌是一个新引入的术语,关于其功能和对肥胖的影响的系统性证据并不多。我们设计了这项研究,以系统回顾不同类型的益生菌对肥胖的影响:方法:我们使用 PubMed、SCOPUS 和 Web of Science 数据库对截至 2023 年 8 月的研究进行了系统检索。研究任何类型的益生菌对肥胖和肥胖相关因素影响的人类和动物干预性研究均符合条件。筛选、数据提取和质量评估由两名研究人员独立完成。研究质量采用 Cochrane 和实验动物实验系统综述中心(SYRCLE)的偏倚风险工具进行评估:在检索到的 19373 项研究中,最终纳入了 49 项研究(9 项人类研究和 40 项动物研究)。使用最多的益生菌是短链脂肪酸和热杀死(灭活)细菌。在人体临床试验中,口服灭活的淀粉乳杆菌(CP1563)、动物双歧杆菌亚种(CECT 8145)和五味子球菌(LP28)作为益生元,可改善身体组成和人体测量指数。动物研究评估了其他类型的益生元,包括氨酰二肽、无细胞提取物、尿石素 A 和 B、细胞外囊泡、外多糖和表面层蛋白,支持益生元的抗肥胖作用:结论:益生菌后似乎是一种安全的干预措施,其结果有利于减少脂肪生成和增加能量消耗。对于这个相对较新的课题,还需要进一步开展高质量的研究。
{"title":"The anti-obesity effects of postbiotics: A systematic review of pre-clinical and clinical studies","authors":"Maysa Eslami ,&nbsp;Azin Pakmehr ,&nbsp;Farzad Pourghazi ,&nbsp;Atefe Kami ,&nbsp;Hanieh-Sadat Ejtahed ,&nbsp;Mohammadreza Mohajeri-Tehrani ,&nbsp;Shirin Hasani-Ranjbar ,&nbsp;Bagher Larijani","doi":"10.1016/j.clnesp.2024.10.153","DOIUrl":"10.1016/j.clnesp.2024.10.153","url":null,"abstract":"<div><h3>Background</h3><div>The growing prevalence of obesity has become a major concern worldwide, therefore a great number of studies are conducted every day in the field of obesity. Since postbiotics are a newly introduced term, there is not much systematic evidence about their function and impact on obesity. We designed this study to systematically review the effect of different types of postbiotics on obesity.</div></div><div><h3>Methods</h3><div>A systematic search was conducted using PubMed, SCOPUS, and Web of Science databases up to August 2023. Both human and animal interventional studies that investigated the effects of any type of postbiotic on obesity and obesity-related factors were eligible. Screening, data extraction, and quality assessment were conducted independently by two researchers. The quality of the studies was appraised using Cochrane and Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE's) risk of bias tool.</div></div><div><h3>Results</h3><div>Of the 19373 retrieved studies, finally, 49 studies were included (9 human studies and 40 animal studies). Short-chain fatty acids and heat-killed (inactivated) bacteria were the most used postbiotics. In human clinical trials, inactivated <em>Lactobacillus amylovorus</em> (CP1563), <em>Bifidobacterium animalis</em> subsp. <em>lactis</em> (CECT 8145) and <em>Pediococcus pentosaceus</em> (LP28) were administered orally as postbiotics which improved body composition and anthropometric indices. Animal studies evaluated other types of postbiotics including muramyl dipeptide, cell-free extracts, urolithin A&amp;B, extracellular Vesicles, exopolysaccharides, and surface Layer Proteins, supporting the anti-obesity effects of postbiotics.</div></div><div><h3>Conclusion</h3><div>Postbiotics seem to be a safe intervention and the results were in favor of a reduction in adipogenesis as well as an increase in energy expenditure. Further high-quality studies are required in this relatively new topic.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 370-389"},"PeriodicalIF":2.9,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between Ward's triangle bone mineral density levels and abdominal aortic calcification: Data from the national health and nutrition examination survey 2013–2014 沃德三角区骨矿密度水平与腹主动脉钙化之间的关系:来自 2013-2014 年全国健康与营养调查的数据。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-24 DOI: 10.1016/j.clnesp.2024.10.154
Mengmeng Wang , Degang Mo , Chi Zhou , Mengqi Guo , Wenqiang Zhang , Rui Chen , Jiachao Xu , Ning Zhang , Haichu Yu

Background & aims

Despite extensive research into the cardiovascular implications of abdominal aortic calcification (AAC), there is a scarcity of robust studies exploring its association with Ward's triangle bone mineral density (BMD). This study aimed to evaluate this relationship in a nationally representative sample and compare the predictive value with femoral neck BMD and total femur BMD.

Methods

We conducted a cross-sectional analysis of 2013–2014 National Health and Nutrition Examination Survey (NHANES) data, utilizing a complex, stratified, multistage, cluster sampling design. BMD measurements at Ward's triangle, femoral neck, and total femur were assessed using DXA scans. AAC severity was defined by a Kauppila score of ≥5. Predictors of AAC-24 scores were identified through correlation and linear regression models. Stratified regression and restricted cubic splines were applied to explore subgroup and dose–response relationships.

Results

Of the 2965 participants representing 116, 562, 500 individuals in the U.S., 11 % had severe AAC. Ward's triangle BMD showed a significant negative association with AAC-24 scores (β = −1.90, 95 % CI: −2.80 to −1.00, P < 0.002) and a reduced risk of severe AAC (OR = 0.85, 95 % CI: 0.76 to 0.95, P = 0.010). Non-linear associations were observed between Ward's triangle BMD and AAC outcomes. Ward's triangle BMD outperformed femoral neck and total femur BMD in predicting AAC.

Conclusions

Higher Ward's triangle BMD is linked to lower odds of severe AAC, highlighting its potential for improved early detection of AAC over femoral neck and total femur BMD. Healthcare providers should consider the implications of reduced Ward's triangle BMD for systemic atherosclerosis and recommend early AAC screening for enhanced cardiovascular risk management.
背景与目的:尽管对腹主动脉钙化(AAC)对心血管的影响进行了广泛的研究,但很少有可靠的研究探讨其与沃德氏三角区骨矿物质密度(BMD)的关系。本研究旨在评估全国代表性样本中的这种关系,并比较其与股骨颈 BMD 和总股骨 BMD 的预测价值:我们对 2013-2014 年美国国家健康与营养调查 (NHANES) 数据进行了横断面分析,采用了复杂的分层、多阶段、群组抽样设计。使用 DXA 扫描评估了沃德三角区、股骨颈和全股骨的 BMD 测量值。AAC严重程度由Kauppila评分≥5来定义。通过相关性和线性回归模型确定了 AAC-24 评分的预测因素。应用分层回归和限制性立方样条来探讨亚组和剂量反应关系:在代表美国 1.165625 亿人的 2965 名参与者中,11% 的人患有严重的 AAC。Ward's 三角形 BMD 与 AAC-24 评分呈显著负相关(β = -1.90, 95% CI: -2.80 to -1.00, P < 0.002),并降低了严重 AAC 的风险(OR = 0.85, 95% CI: 0.76 to 0.95, P = 0.010)。Ward's 三角形 BMD 与 AAC 结果之间存在非线性关联。在预测 AAC 方面,Ward's 三角区 BMD 优于股骨颈和全股骨 BMD:结论:较高的沃德三角区 BMD 与较低的严重 AAC 发生几率有关,这表明沃德三角区 BMD 比股骨颈和股骨总 BMD 更有潜力提高 AAC 的早期发现率。医疗服务提供者应考虑沃德氏三角区 BMD 降低对全身动脉粥样硬化的影响,并建议进行早期 AAC 筛查,以加强心血管风险管理。
{"title":"Association between Ward's triangle bone mineral density levels and abdominal aortic calcification: Data from the national health and nutrition examination survey 2013–2014","authors":"Mengmeng Wang ,&nbsp;Degang Mo ,&nbsp;Chi Zhou ,&nbsp;Mengqi Guo ,&nbsp;Wenqiang Zhang ,&nbsp;Rui Chen ,&nbsp;Jiachao Xu ,&nbsp;Ning Zhang ,&nbsp;Haichu Yu","doi":"10.1016/j.clnesp.2024.10.154","DOIUrl":"10.1016/j.clnesp.2024.10.154","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Despite extensive research into the cardiovascular implications of abdominal aortic calcification (AAC), there is a scarcity of robust studies exploring its association with Ward's triangle bone mineral density (BMD). This study aimed to evaluate this relationship in a nationally representative sample and compare the predictive value with femoral neck BMD and total femur BMD.</div></div><div><h3>Methods</h3><div>We conducted a cross-sectional analysis of 2013–2014 National Health and Nutrition Examination Survey (NHANES) data, utilizing a complex, stratified, multistage, cluster sampling design. BMD measurements at Ward's triangle, femoral neck, and total femur were assessed using DXA scans. AAC severity was defined by a Kauppila score of ≥5. Predictors of AAC-24 scores were identified through correlation and linear regression models. Stratified regression and restricted cubic splines were applied to explore subgroup and dose–response relationships.</div></div><div><h3>Results</h3><div>Of the 2965 participants representing 116, 562, 500 individuals in the U.S., 11 % had severe AAC. Ward's triangle BMD showed a significant negative association with AAC-24 scores (β = −1.90, 95 % CI: −2.80 to −1.00, P &lt; 0.002) and a reduced risk of severe AAC (OR = 0.85, 95 % CI: 0.76 to 0.95, P = 0.010). Non-linear associations were observed between Ward's triangle BMD and AAC outcomes. Ward's triangle BMD outperformed femoral neck and total femur BMD in predicting AAC.</div></div><div><h3>Conclusions</h3><div>Higher Ward's triangle BMD is linked to lower odds of severe AAC, highlighting its potential for improved early detection of AAC over femoral neck and total femur BMD. Healthcare providers should consider the implications of reduced Ward's triangle BMD for systemic atherosclerosis and recommend early AAC screening for enhanced cardiovascular risk management.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 344-357"},"PeriodicalIF":2.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The post ICU trajectory: Post acute and post ICU nutritional care 重症监护室后的轨迹:急诊室和重症监护室后的营养护理。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-24 DOI: 10.1016/j.clnesp.2024.10.151
Pierre Singer
ICU survivors are growing but a persistent physical and mental disability may occur. The patients discharged from ICU are frequently malnourished and their medical nutritional support is impaired by oral intake limitation due to respiratory support such as non invasive ventilation or high flow nasal cannula oxygen therapy, dysphagia and difficulties to determine energy and protein targets. ICU acquired weakness must be recognized and could be minimized by better energy intake determined by indirect calorimetry, optimal protein intake and physical activity. Early physical activity has become a pivotal element of the improvement of the physical and cognitive condition in the post ICU.
重症监护室的幸存者在不断成长,但可能会出现持续的身体和精神残疾。从重症监护室出院的病人经常营养不良,由于呼吸支持(如无创通气或高流量鼻插管氧疗)、吞咽困难以及难以确定能量和蛋白质目标,他们的口服营养支持受到了影响。必须认识到重症监护室后天性体质虚弱的问题,并通过间接热量测量法确定更好的能量摄入量、最佳蛋白质摄入量和体育锻炼来尽量减少体质虚弱。早期体育锻炼已成为改善重症监护室术后患者身体和认知状况的关键因素。
{"title":"The post ICU trajectory: Post acute and post ICU nutritional care","authors":"Pierre Singer","doi":"10.1016/j.clnesp.2024.10.151","DOIUrl":"10.1016/j.clnesp.2024.10.151","url":null,"abstract":"<div><div>ICU survivors are growing but a persistent physical and mental disability may occur. The patients discharged from ICU are frequently malnourished and their medical nutritional support is impaired by oral intake limitation due to respiratory support such as non invasive ventilation or high flow nasal cannula oxygen therapy, dysphagia and difficulties to determine energy and protein targets. ICU acquired weakness must be recognized and could be minimized by better energy intake determined by indirect calorimetry, optimal protein intake and physical activity. Early physical activity has become a pivotal element of the improvement of the physical and cognitive condition in the post ICU.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 441-446"},"PeriodicalIF":2.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the editor: Comment on “effects of probiotics on sleep parameters: A systematic review and meta-analysis" 致编辑的信关于 "益生菌对睡眠参数的影响:系统回顾和荟萃分析 "发表评论。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-24 DOI: 10.1016/j.clnesp.2024.10.156
Rachana Mehta, Ashok Kumar Balaraman, Muhammed Shabil, Sanjit Sah
{"title":"Letter to the editor: Comment on “effects of probiotics on sleep parameters: A systematic review and meta-analysis\"","authors":"Rachana Mehta,&nbsp;Ashok Kumar Balaraman,&nbsp;Muhammed Shabil,&nbsp;Sanjit Sah","doi":"10.1016/j.clnesp.2024.10.156","DOIUrl":"10.1016/j.clnesp.2024.10.156","url":null,"abstract":"","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 332-333"},"PeriodicalIF":2.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Underpowered studies in muscle metabolism research: Determinants and considerations 肌肉代谢研究中力量不足的研究:决定因素和考虑因素。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-24 DOI: 10.1016/j.clnesp.2024.10.152
Dion C.J. Houtvast , Milan W. Betz , Bas Van Hooren , Sophie Vanbelle , Lex B. Verdijk , Luc J.C. van Loon , Jorn Trommelen
Biomedical research frequently employs null hypothesis testing to determine whether an observed difference in a sample is likely to exist in the broader population. Null hypothesis testing generally assumes that differences between groups or interventions are non-existent, unless proven otherwise. Because biomedical studies with human subjects are often limited by financial and logistical resources, they tend to have low statistical power, i.e. a low probability of statistically confirming a true difference. As a result, small but potentially clinically important differences may be overseen or ignored simply due to the absence of a statistically significant difference. This absence is often misinterpreted as ‘equivalence’ of treatments. In this educational paper, we will use practical examples related to the effects of exercise and nutrition on muscle protein metabolism to illustrate the most important determinants of statistical power, as well as their implications for both investigators and readers of scientific articles.
Changes in muscle mass occur at a relatively slow rate, making it practically challenging to detect differences between treatment groups in a long-term setting. One way to make it ‘easier’ to differentiate between groups and hence increase statistical power is to have a sufficiently long study duration to allow treatment effects to become apparent. This is especially relevant when comparing treatments with relatively small expected differences such as the effect of modest changes in daily protein intake. Secondly, one could try to minimize the variance and response heterogeneity within groups, for example by using strict inclusion criteria and standardization protocols (e.g., meal provision), by using cross-over designs, or even within-subject designs where two interventions are compared simultaneously (e.g., studying an exercised limb vs a contralateral control limb) although this might limit the generalizability of the findings (e.g. such single-limb exercise training is not common in practice). In terms of data interpretation, investigators should obviously refrain from drawing strong conclusions from underpowered studies. Yet, such studies still provide valuable data for meta-analyses. Finally, because muscle protein synthesis rates are highly responsive to anabolic stimuli, acute metabolic studies are more sensitive to detect potentially clinically relevant differences in the anabolic response between treatments. Apart from further elaborating on these topics, this educational article encourages readers to more critically question null findings and scientists to more clearly discuss limitations that may have compromised statistical power.
生物医学研究经常使用零假设检验来确定在样本中观察到的差异是否可能存在于更广泛的人群中。零假设检验通常假定组间或干预措施间的差异不存在,除非事实证明并非如此。由于以人为对象的生物医学研究往往受到财政和后勤资源的限制,因此它们的统计能力往往较低,即在统计上证实真实差异的概率较低。因此,微小但可能具有重要临床意义的差异可能会被忽略,或仅仅因为没有统计学意义上的显著差异而被忽略。这种差异往往被误解为治疗的 "等效性"。在这篇教育论文中,我们将使用与运动和营养对肌肉蛋白质代谢的影响有关的实际例子来说明统计能力的最重要决定因素,以及它们对研究人员和科学文章读者的影响。肌肉质量的变化速度相对较慢,因此在长期环境中检测治疗组之间的差异实际上具有挑战性。要想 "更容易 "区分不同组别,从而提高统计能力,方法之一是进行足够长的研究,使治疗效果显现出来。这一点在比较预期差异相对较小的治疗方法时尤为重要,例如每日蛋白质摄入量的适度变化所产生的影响。其次,我们可以尝试尽量减少组内差异和反应异质性,例如采用严格的纳入标准和标准化方案(如提供膳食),采用交叉设计,甚至采用同时比较两种干预措施的受试者内设计(如研究锻炼肢体与对侧对照肢体),不过这可能会限制研究结果的普遍性(如这种单肢锻炼训练在实践中并不常见)。在数据解释方面,研究人员显然应该避免从动力不足的研究中得出有力的结论。然而,这类研究仍能为荟萃分析提供有价值的数据。最后,由于肌肉蛋白质合成率对合成代谢刺激具有高度反应性,因此急性代谢研究对检测不同治疗之间合成代谢反应的潜在临床相关差异更为敏感。除了进一步阐述这些主题外,这篇教育性文章还鼓励读者对无效研究结果提出更严格的质疑,并鼓励科学家更清楚地讨论可能影响统计能力的局限性。
{"title":"Underpowered studies in muscle metabolism research: Determinants and considerations","authors":"Dion C.J. Houtvast ,&nbsp;Milan W. Betz ,&nbsp;Bas Van Hooren ,&nbsp;Sophie Vanbelle ,&nbsp;Lex B. Verdijk ,&nbsp;Luc J.C. van Loon ,&nbsp;Jorn Trommelen","doi":"10.1016/j.clnesp.2024.10.152","DOIUrl":"10.1016/j.clnesp.2024.10.152","url":null,"abstract":"<div><div>Biomedical research frequently employs null hypothesis testing to determine whether an observed difference in a sample is likely to exist in the broader population. Null hypothesis testing generally assumes that differences between groups or interventions are non-existent, unless proven otherwise. Because biomedical studies with human subjects are often limited by financial and logistical resources, they tend to have low statistical power, i.e. a low probability of statistically confirming a true difference. As a result, small but potentially clinically important differences may be overseen or ignored simply due to the absence of a statistically significant difference. This absence is often misinterpreted as ‘equivalence’ of treatments. In this educational paper, we will use practical examples related to the effects of exercise and nutrition on muscle protein metabolism to illustrate the most important determinants of statistical power, as well as their implications for both investigators and readers of scientific articles.</div><div>Changes in muscle mass occur at a relatively slow rate, making it practically challenging to detect differences between treatment groups in a long-term setting. One way to make it ‘easier’ to differentiate between groups and hence increase statistical power is to have a sufficiently long study duration to allow treatment effects to become apparent. This is especially relevant when comparing treatments with relatively small expected differences such as the effect of modest changes in daily protein intake. Secondly, one could try to minimize the variance and response heterogeneity within groups, for example by using strict inclusion criteria and standardization protocols (e.g., meal provision), by using cross-over designs, or even within-subject designs where two interventions are compared simultaneously (e.g., studying an exercised limb vs a contralateral control limb) although this might limit the generalizability of the findings (e.g. such single-limb exercise training is not common in practice). In terms of data interpretation, investigators should obviously refrain from drawing strong conclusions from underpowered studies. Yet, such studies still provide valuable data for meta-analyses. Finally, because muscle protein synthesis rates are highly responsive to anabolic stimuli, acute metabolic studies are more sensitive to detect potentially clinically relevant differences in the anabolic response between treatments. Apart from further elaborating on these topics, this educational article encourages readers to more critically question null findings and scientists to more clearly discuss limitations that may have compromised statistical power.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 334-343"},"PeriodicalIF":2.9,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A descriptive analysis of individually compounded home parenteral nutrition prescriptions provided to adults with chronic intestinal failure 对提供给慢性肠功能衰竭成人的个体化家庭肠外营养处方的描述性分析。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-22 DOI: 10.1016/j.clnesp.2024.10.007
Melanie Baker , Mark Hann , Simon Lal , Sorrel Burden

Background & aims

Home Parenteral Nutrition (HPN) prescriptions should be tailored to a patient's nutritional requirements and comprise of individually compounded regimens (IC-HPN) or standard licensed multi-chamber bags (MCB). There is a paucity of research exploring factors associated with admixture type. This study aimed to evaluate the nutrient composition of adult IC-HPN prescriptions and variance in nutrient dosing, make comparisons with the range of MCB available and dosing recommendations stated in international guidelines.

Methods

This cross-sectional observational study analysed anonymised prescription data for adults under the care of a single home care company in England, commencing IC-HPN after January 2021.

Results

There were 155 patient prescriptions (245 HPN bags) included, with body weight available in 82 (52.9 %) cases. Data were reported for each HPN bag, and summarised as an average daily amount, considering the number of different HPN bags and their daily frequency per patient prescription.
A vast range of nutrients were prescribed, with variance in dosing highest for lipid, phosphate, and calcium; with coefficient of variance of 106 %, 74 % and 67 %, respectively. One-hundred-thirty-four (54.7 %) bags contained lipid, resulting in variable ratios of lipid to aqueous bags provided weekly.
Negligible amounts of at least one electrolyte were prescribed in 93 (38.0 %) bags, of which 52 (21.2 %) contained ≤2 mmol calcium. Compared with MCB (65 bags), IC-HPN bags contained higher amounts of all nutrients, apart from nitrogen and phosphate. Mean sodium intake differed substantially between types of bags (IC-HPN 187.5, SD 100.1 mmol versus MCB 49.1, SD 31.7 mmol, p < 0.001). A substantial number of patients received HPN dosages beyond guideline recommendations, with higher amounts of sodium and fluid provided in 41 (50.0 %) cases; conversely, lower than recommended dosages were seen in 55 (67.1 %) for potassium and 61 (74.4 %) for calcium.

Conclusions

This study has demonstrated vast variance in IC-HPN parenteral nutrient dosing, with minimal or an omission of at least one nutrient seen. Further research is needed to explore factors that influence usage of IC-HPN, clinical reasons related to lipid dosing and around the variation in doses prescribed outside of guideline recommendations.
背景与目的:家庭肠外营养(HPN)处方应根据患者的营养需求量身定制,包括单独复方制剂(IC-HPN)或标准许可多室袋(MCB)。目前还很少有研究探讨与混合剂类型相关的因素。本研究旨在评估成人 IC-HPN 处方的营养成分和营养剂量差异,并与现有的 MCB 范围和国际指南中的剂量建议进行比较:这项横断面观察性研究分析了英格兰一家家庭护理公司护理的成人匿名处方数据,这些成人在 2021 年 1 月后开始接受 IC-HPN 治疗:共有 155 份患者处方(245 个 HPN 袋),其中 82 例(52.9%)有体重数据。考虑到每个患者处方中不同 HPN 袋的数量及其每日使用频率,报告了每个 HPN 袋的数据,并汇总为每日平均用量。处方中的营养素种类繁多,其中血脂、磷酸盐和钙的剂量差异最大;差异系数分别为 106%、74% 和 67%。134袋(54.7%)营养袋含有脂质,导致每周提供的脂质营养袋与水质营养袋的比例各不相同。有 93 袋(38.0%)至少含有一种电解质,其中 52 袋(21.2%)的钙含量小于 2 毫摩尔。与 MCB(65 袋)相比,IC-HPN 袋中除氮和磷酸盐外,所有营养素的含量都较高。不同类型包装袋的平均钠摄入量差别很大(IC-HPN 187.5,SD 100.1 mmol;MCB 49.1,SD 31.7 mmol,p 结论:这项研究表明,IC-HPN 肠外营养素剂量存在巨大差异,至少有一种营养素的剂量极低或遗漏。需要进一步开展研究,探索影响 IC-HPN 使用的因素、与脂质剂量相关的临床原因以及指南建议之外的处方剂量差异。
{"title":"A descriptive analysis of individually compounded home parenteral nutrition prescriptions provided to adults with chronic intestinal failure","authors":"Melanie Baker ,&nbsp;Mark Hann ,&nbsp;Simon Lal ,&nbsp;Sorrel Burden","doi":"10.1016/j.clnesp.2024.10.007","DOIUrl":"10.1016/j.clnesp.2024.10.007","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Home Parenteral Nutrition (HPN) prescriptions should be tailored to a patient's nutritional requirements and comprise of individually compounded regimens (IC-HPN) or standard licensed multi-chamber bags (MCB). There is a paucity of research exploring factors associated with admixture type. This study aimed to evaluate the nutrient composition of adult IC-HPN prescriptions and variance in nutrient dosing, make comparisons with the range of MCB available and dosing recommendations stated in international guidelines.</div></div><div><h3>Methods</h3><div>This cross-sectional observational study analysed anonymised prescription data for adults under the care of a single home care company in England, commencing IC-HPN after January 2021.</div></div><div><h3>Results</h3><div>There were 155 patient prescriptions (245 HPN bags) included, with body weight available in 82 (52.9 %) cases. Data were reported for each HPN bag, and summarised as an average daily amount, considering the number of different HPN bags and their daily frequency per patient prescription.</div><div>A vast range of nutrients were prescribed, with variance in dosing highest for lipid, phosphate, and calcium; with coefficient of variance of 106 %, 74 % and 67 %, respectively. One-hundred-thirty-four (54.7 %) bags contained lipid, resulting in variable ratios of lipid to aqueous bags provided weekly.</div><div>Negligible amounts of at least one electrolyte were prescribed in 93 (38.0 %) bags, of which 52 (21.2 %) contained ≤2 mmol calcium. Compared with MCB (65 bags), IC-HPN bags contained higher amounts of all nutrients, apart from nitrogen and phosphate. Mean sodium intake differed substantially between types of bags (IC-HPN 187.5, SD 100.1 mmol versus MCB 49.1, SD 31.7 mmol, p &lt; 0.001). A substantial number of patients received HPN dosages beyond guideline recommendations, with higher amounts of sodium and fluid provided in 41 (50.0 %) cases; conversely, lower than recommended dosages were seen in 55 (67.1 %) for potassium and 61 (74.4 %) for calcium.</div></div><div><h3>Conclusions</h3><div>This study has demonstrated vast variance in IC-HPN parenteral nutrient dosing, with minimal or an omission of at least one nutrient seen. Further research is needed to explore factors that influence usage of IC-HPN, clinical reasons related to lipid dosing and around the variation in doses prescribed outside of guideline recommendations.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 324-331"},"PeriodicalIF":2.9,"publicationDate":"2024-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142496286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “A pilot randomized controlled trial of a telenutrition weight loss program supported with telemonitoring and health coaching in overweight and obese adults” [Clin Nutr ESPEN 63 (2024) 1312–1322] 对 "在超重和肥胖成年人中开展远程监测和健康指导支持的远程营养减肥计划的试点随机对照试验 "的更正 [Clin Nutr ESPEN 63 (2024) 1312-1322]
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-19 DOI: 10.1016/j.clnesp.2024.10.144
N. Eid , R. Mosli , S. Enani , R. Saqr , E. Al-ofi , K. Qutah , S. Eid
{"title":"Corrigendum to “A pilot randomized controlled trial of a telenutrition weight loss program supported with telemonitoring and health coaching in overweight and obese adults” [Clin Nutr ESPEN 63 (2024) 1312–1322]","authors":"N. Eid ,&nbsp;R. Mosli ,&nbsp;S. Enani ,&nbsp;R. Saqr ,&nbsp;E. Al-ofi ,&nbsp;K. Qutah ,&nbsp;S. Eid","doi":"10.1016/j.clnesp.2024.10.144","DOIUrl":"10.1016/j.clnesp.2024.10.144","url":null,"abstract":"","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Page 236"},"PeriodicalIF":2.9,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrition in phenylketonuria 苯丙酮尿症的营养问题。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-19 DOI: 10.1016/j.clnesp.2024.09.032
Saeedeh Talebi , Peyman Eshraghi
Phenylketonuria (PKU) is a genetic metabolic disease resulting from a deficiency in the enzyme phenylalanine hydroxylase. This defect prevents the conversion of phenylalanine to tyrosine, and as a result, the level of phenylalanine in the body increases abnormally. The accumulation of this amino acid may cause brain damage and grows development in these patients.
The primary approach to treating the disease involves dietary management that restricts protein and phenylalanine intake, often alongside Tetrahydrobiopterin (BH4) supplementation. Medical foods specifically formulated for these patients are utilized to supply the necessary energy, protein, and tyrosine. Other treatment options, including the use of large neutral amino acids (LNAAs) and the enzyme Phenylalanine ammonia lyase (PAL), can be utilized to manage symptoms in adult patients. Advancements in gene therapy aimed at correcting defective genes in patients may help restore phenylalanine metabolism, though further research in this area is necessary. Effective personal management of phenylketonuria necessitates enhanced knowledge and collaboration among healthcare professionals to achieve optimal treatment outcomes for patients. This article emphasis the nutritional management of individuals with phenylketonuria across various stages of their lives.
苯丙酮尿症(PKU)是一种因苯丙氨酸羟化酶缺乏而导致的遗传代谢病。这种缺陷阻碍了苯丙氨酸向酪氨酸的转化,导致体内苯丙氨酸水平异常升高。这种氨基酸的积累可能会导致这些患者的脑损伤和生长发育。治疗这种疾病的主要方法是进行饮食管理,限制蛋白质和苯丙氨酸的摄入量,通常同时补充四氢生物蝶呤(BH4)。专为这些患者配制的医用食品可提供必要的能量、蛋白质和酪氨酸。其他治疗方法,包括使用大分子中性氨基酸(LNAAs)和苯丙氨酸氨裂解酶(PAL),可用于控制成年患者的症状。旨在纠正患者缺陷基因的基因治疗技术的进步可能有助于恢复苯丙氨酸代谢,但这一领域的研究仍需进一步深入。要对苯丙酮尿症进行有效的个人管理,就必须加强医疗保健专业人员之间的知识交流与合作,以实现患者的最佳治疗效果。这篇文章强调了苯丙酮尿症患者在人生不同阶段的营养管理。
{"title":"Nutrition in phenylketonuria","authors":"Saeedeh Talebi ,&nbsp;Peyman Eshraghi","doi":"10.1016/j.clnesp.2024.09.032","DOIUrl":"10.1016/j.clnesp.2024.09.032","url":null,"abstract":"<div><div>Phenylketonuria (PKU) is a genetic metabolic disease resulting from a deficiency in the enzyme phenylalanine hydroxylase. This defect prevents the conversion of phenylalanine to tyrosine, and as a result, the level of phenylalanine in the body increases abnormally. The accumulation of this amino acid may cause brain damage and grows development in these patients.</div><div>The primary approach to treating the disease involves dietary management that restricts protein and phenylalanine intake, often alongside Tetrahydrobiopterin (BH4) supplementation. Medical foods specifically formulated for these patients are utilized to supply the necessary energy, protein, and tyrosine. Other treatment options, including the use of large neutral amino acids (LNAAs) and the enzyme Phenylalanine ammonia lyase (PAL), can be utilized to manage symptoms in adult patients. Advancements in gene therapy aimed at correcting defective genes in patients may help restore phenylalanine metabolism, though further research in this area is necessary. Effective personal management of phenylketonuria necessitates enhanced knowledge and collaboration among healthcare professionals to achieve optimal treatment outcomes for patients. This article emphasis the nutritional management of individuals with phenylketonuria across various stages of their lives.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 307-313"},"PeriodicalIF":2.9,"publicationDate":"2024-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142459558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poor oral status at stroke onset negatively affects activities of daily living at discharge: A propensity-score analysis 中风发病时口腔状况不佳会对出院时的日常生活活动产生负面影响:倾向分数分析。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-18 DOI: 10.1016/j.clnesp.2024.10.147
Takuma Mogamiya , Yuki Ohshima , Hiromasa Takashima , Shinya Matsushima , Takuma Watanabe , Misako Mori , Yuta Hagiwara , Hidetaka Onodera

Background & aims

Poor oral status during stroke recovery can cause malnutrition, which can markedly affect activities of daily living and prevent patients from being discharged home. Therefore, prompt evaluation and treatment of oral disorders immediately after stroke is essential. This study aimed to examine the impact of poor oral status on the post-stroke recovery of independence in activities of daily living and home discharge.

Methods

This single-center retrospective observational study included 137 patients with acute stroke, divided into two groups based on their Oral Assessment Guide (OAG) scores: the normal OAG group (score = 8) and the impaired OAG group (scores ≥9). Propensity-score matching was performed to minimize confounding variables. The χ2 test and odds ratios were used to compare the percentage of independence and home discharges between the two groups.

Results

The normal and impaired OAG groups exhibited no difference in neurological severity or nutritional intake after matching. The percentage of patients achieving independence in activities of daily living in the normal OAG group (86.8 %) was significantly higher than that in the impaired OAG group (65.8 %) (p = 0.03, odds ratio [OR] 0.29, 95 % confidence interval [CI] 0.09–0.92). Conversely, no significant difference in the percentage of patients discharged home was found (p = 0.15, OR 0.49, 95%CI 0.19–1.29).

Conclusions

This study found that poor oral status after stroke onset was an independent factor affecting independence in activities of daily living at discharge, irrespective of neurological severity and dietary intake.
背景与目的:中风恢复期口腔状况不佳会导致营养不良,严重影响日常生活活动,使患者无法出院回家。因此,中风后及时评估和治疗口腔疾病至关重要。本研究旨在探讨口腔状况不佳对脑卒中后日常生活自理能力恢复和出院的影响:这项单中心回顾性观察研究纳入了 137 名急性脑卒中患者,根据他们的《口腔评估指南》(OAG)评分分为两组:OAG 正常组(评分=8)和 OAG 受损组(评分≥9)。进行倾向分数匹配以尽量减少混杂变量。采用χ2检验和几率比验比较两组患者独立和出院的百分比:结果:配对后,OAG正常组和OAG受损组在神经系统严重程度和营养摄入方面没有差异。正常 OAG 组实现日常生活自理的比例(86.8%)明显高于受损 OAG 组(65.8%)(P=0.03,几率比 [OR] 0.29,95% 置信区间 [CI]0.09-0.92)。相反,出院回家的患者比例没有发现明显差异(P=0.15,OR 0.49,95%CI 0.19-1.29):本研究发现,卒中发生后口腔状况不佳是影响出院时日常生活活动独立性的一个独立因素,与神经严重程度和饮食摄入无关。
{"title":"Poor oral status at stroke onset negatively affects activities of daily living at discharge: A propensity-score analysis","authors":"Takuma Mogamiya ,&nbsp;Yuki Ohshima ,&nbsp;Hiromasa Takashima ,&nbsp;Shinya Matsushima ,&nbsp;Takuma Watanabe ,&nbsp;Misako Mori ,&nbsp;Yuta Hagiwara ,&nbsp;Hidetaka Onodera","doi":"10.1016/j.clnesp.2024.10.147","DOIUrl":"10.1016/j.clnesp.2024.10.147","url":null,"abstract":"<div><h3>Background &amp; aims</h3><div>Poor oral status during stroke recovery can cause malnutrition, which can markedly affect activities of daily living and prevent patients from being discharged home. Therefore, prompt evaluation and treatment of oral disorders immediately after stroke is essential. This study aimed to examine the impact of poor oral status on the post-stroke recovery of independence in activities of daily living and home discharge.</div></div><div><h3>Methods</h3><div>This single-center retrospective observational study included 137 patients with acute stroke, divided into two groups based on their Oral Assessment Guide (OAG) scores: the normal OAG group (score = 8) and the impaired OAG group (scores ≥9). Propensity-score matching was performed to minimize confounding variables. The χ2 test and odds ratios were used to compare the percentage of independence and home discharges between the two groups.</div></div><div><h3>Results</h3><div>The normal and impaired OAG groups exhibited no difference in neurological severity or nutritional intake after matching. The percentage of patients achieving independence in activities of daily living in the normal OAG group (86.8 %) was significantly higher than that in the impaired OAG group (65.8 %) (p = 0.03, odds ratio [OR] 0.29, 95 % confidence interval [CI] 0.09–0.92). Conversely, no significant difference in the percentage of patients discharged home was found (p = 0.15, OR 0.49, 95%CI 0.19–1.29).</div></div><div><h3>Conclusions</h3><div>This study found that poor oral status after stroke onset was an independent factor affecting independence in activities of daily living at discharge, irrespective of neurological severity and dietary intake.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 237-243"},"PeriodicalIF":2.9,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142459559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nutrigenomics-guided lifestyle intervention programmes: A critical scoping review with directions for future research 营养基因组学指导下的生活方式干预计划:重要范围综述与未来研究方向。
IF 2.9 Q3 NUTRITION & DIETETICS Pub Date : 2024-10-18 DOI: 10.1016/j.clnesp.2024.10.149
Saba Aljasir , Noura M.S. Eid , Emanuela V. Volpi , Ihab Tewfik
Genetic testing is increasingly used in clinical practice to provide personalized information and recommendations about health risks and lifestyle habits at a relatively low cost. Research on the effectiveness of nutrigenomics-guided lifestyle interventions is growing. A scoping review approach was adopted to identify pertinent published studies on nutrigenomics-guided intervention programmes from 2007 to 2023. The review shows that despite the growing interest in nutrigenomics-guided lifestyle interventions, there are still few empirically supported studies, primarily based on developed countries. Furthermore, the findings on the impact of personalised genetic advice are mixed, leaving the field unclear. Existing studies have some empirical strength, contributing to further understanding of the relationship between food and gene expression. However, some limitations that affect the robustness of findings exist, such as a small sample size, insufficient monitoring of the data collection process, and a short follow-up period. Future research needs to address reliability concerns and provide more robust practical evidence.
基因检测越来越多地应用于临床实践,以相对较低的成本提供有关健康风险和生活习惯的个性化信息和建议。有关以营养基因组学为指导的生活方式干预措施有效性的研究正在不断增加。我们采用了范围综述的方法,以确定从 2007 年到 2023 年发表的有关营养基因组学指导下的干预计划的相关研究。综述显示,尽管人们对营养基因组学指导下的生活方式干预越来越感兴趣,但有经验支持的研究仍然很少,而且主要是基于发达国家的研究。此外,关于个性化基因建议的影响的研究结果也是喜忧参半,使该领域的研究尚不明确。现有研究具有一定的经验优势,有助于进一步了解食物与基因表达之间的关系。不过,也存在一些影响研究结果稳健性的局限性,如样本量较小、对数据收集过程的监控不足、随访时间较短等。未来的研究需要解决可靠性问题,并提供更有力的实际证据。
{"title":"Nutrigenomics-guided lifestyle intervention programmes: A critical scoping review with directions for future research","authors":"Saba Aljasir ,&nbsp;Noura M.S. Eid ,&nbsp;Emanuela V. Volpi ,&nbsp;Ihab Tewfik","doi":"10.1016/j.clnesp.2024.10.149","DOIUrl":"10.1016/j.clnesp.2024.10.149","url":null,"abstract":"<div><div>Genetic testing is increasingly used in clinical practice to provide personalized information and recommendations about health risks and lifestyle habits at a relatively low cost. Research on the effectiveness of nutrigenomics-guided lifestyle interventions is growing. A scoping review approach was adopted to identify pertinent published studies on nutrigenomics-guided intervention programmes from 2007 to 2023. The review shows that despite the growing interest in nutrigenomics-guided lifestyle interventions, there are still few empirically supported studies, primarily based on developed countries. Furthermore, the findings on the impact of personalised genetic advice are mixed, leaving the field unclear. Existing studies have some empirical strength, contributing to further understanding of the relationship between food and gene expression. However, some limitations that affect the robustness of findings exist, such as a small sample size, insufficient monitoring of the data collection process, and a short follow-up period. Future research needs to address reliability concerns and provide more robust practical evidence.</div></div>","PeriodicalId":10352,"journal":{"name":"Clinical nutrition ESPEN","volume":"64 ","pages":"Pages 296-306"},"PeriodicalIF":2.9,"publicationDate":"2024-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142459557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical nutrition ESPEN
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1